NKX2-8 and breast carcinoma: Furthermore, statistical analysis showed that patients with NKX2-8 high-expressing breast cancer had much longer bone-metastasis-free survival than the patients with NKX2-8 low-expressing breast cancer (P = 0.011 and Figure 1D).